<\/p>\n
\ud83d\udca1 \u0411\u044a\u0440\u0437 \u043e\u0442\u0433\u043e\u0432\u043e\u0440<\/strong><\/p>\n Nafodil<\/strong> \u0435 naftopidil<\/strong>, a selective alpha-1D adrenergic blocker used for BPH-related lower urinary tract symptoms (LUTS) \u2014 particularly storage symptoms (urgency, frequency, nocturia). Developed in Japan and widely used in East Asia but less common in Western markets. Typical dose: 25\u201375 mg once daily. Works within days to weeks; distinct side-effect profile vs tamsulosin.<\/p>\n<\/div>\n \ud83d\udce6 \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u043a\u0440\u0438\u0442\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u041f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u043f\u043e\u0432\u0442\u043e\u0440\u043d\u0430 \u0438\u0437\u043f\u0440\u0430\u0442\u043a\u0430<\/strong><\/a> \u2014 \u0430\u043a\u043e \u0432\u0430\u0448\u0430\u0442\u0430 \u043f\u0440\u0430\u0442\u043a\u0430 \u043d\u0435 \u043f\u0440\u0438\u0441\u0442\u0438\u0433\u043d\u0435 \u0432 \u0440\u0430\u043c\u043a\u0438\u0442\u0435 \u043d\u0430 20 \u0440\u0430\u0431\u043e\u0442\u043d\u0438 \u0434\u043d\u0438, \u043d\u0438\u0435 \u044f \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043c\u0435 \u043e\u0442\u043d\u043e\u0432\u043e.<\/p>\n \u041d\u0430\u0448\u0438\u0442\u0435 \u0433\u0435\u043d\u0435\u0440\u0438\u0447\u043d\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u0441\u0435 \u0434\u043e\u0441\u0442\u0430\u0432\u044f\u0442 \u043e\u0442 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b\u0438, \u0441\u0435\u0440\u0442\u0438\u0444\u0438\u0446\u0438\u0440\u0430\u043d\u0438 \u043e\u0442 WHO-GMP, \u0438 \u0441\u0435 \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u0442 \u043f\u043e \u0446\u0435\u043b\u0438\u044f \u0441\u0432\u044f\u0442 \u0432 \u0434\u0438\u0441\u043a\u0440\u0435\u0442\u043d\u0430, \u043e\u0431\u0438\u043a\u043d\u043e\u0432\u0435\u043d\u0430 \u043e\u043f\u0430\u043a\u043e\u0432\u043a\u0430 \u2014 \u0431\u0435\u0437 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e\u0442\u043e \u0432\u044a\u043d\u0448\u043d\u043e \u043d\u0430 \u043f\u0440\u0430\u0442\u043a\u0430\u0442\u0430. \u041f\u043b\u0430\u0449\u0430\u043d\u0438\u044f\u0442\u0430 \u0441 \u043a\u0430\u0440\u0442\u0430 \u0441\u0435 \u043e\u0431\u0440\u0430\u0431\u043e\u0442\u0432\u0430\u0442 \u0447\u0440\u0435\u0437 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 (\u043e\u043f\u0438\u0441\u0430\u043d\u0438\u0435\u0442\u043e \u043d\u0430 \u0438\u0437\u0432\u043b\u0435\u0447\u0435\u043d\u0438\u0435\u0442\u043e \u0432\u043a\u043b\u044e\u0447\u0432\u0430 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 \u0437\u0430 \u043f\u043b\u0430\u0449\u0430\u043d\u0435 \u0441 \u043a\u0430\u0440\u0442\u0430 \u2014 \u043d\u0438\u043a\u043e\u0433\u0430 \u201cMedsBase\u201d \u0438\u043b\u0438 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e). \u041f\u0440\u0438\u0435\u043c\u0430\u0442 \u0441\u0435 \u0441\u044a\u0449\u043e \u043a\u0440\u0438\u043f\u0442\u043e\u0432\u0430\u043b\u0443\u0442\u0438 \u0438 \u0431\u0430\u043d\u043a\u043e\u0432 \u043f\u0440\u0435\u0432\u043e\u0434 SEPA. \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u0434\u043a\u0440\u0435\u043f\u0435\u043d\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u043f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u0433\u0430\u0440\u0430\u043d\u0442\u0438\u0440\u0430\u043d\u043e \u043f\u0440\u0435\u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043d\u0435.<\/p>\n Nafodil is a branded generic of naftopidil<\/strong>, an alpha-1 adrenergic blocker with preferential selectivity for the alpha-1D receptor subtype<\/strong>. While tamsulosin targets alpha-1A (predominant in prostate smooth muscle), naftopidil targets alpha-1D (predominant in bladder body and spinal cord). This gives naftopidil a different symptomatic profile:<\/p>\n Strengths available: 25 mg, 50 mg, 75 mg<\/strong>. Manufactured by Emcure.<\/p>\n \u0427\u0435\u0441\u0442\u043e (\u22651%):<\/strong> dizziness, headache, orthostatic hypotension, somnolence, nasal congestion.<\/p>\n Less common than tamsulosin:<\/strong> retrograde\/reduced ejaculation. This is naftopidil’s clinical advantage.<\/p>\n \u0420\u044f\u0434\u043a\u043e \u0441\u0435\u0440\u0438\u043e\u0437\u043d\u0438:<\/strong> syncope, priapism, Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery \u2014 share with ophthalmologist.<\/p>\n Both are selective alpha-blockers for BPH, but they target different receptor subtypes \u2014 tamsulosin prefers alpha-1A (more prostatic), naftopidil prefers alpha-1D (more bladder body). Clinical implications:<\/p>\n Store at room temperature (15\u201330 \u00b0C \/ 59\u201386 \u00b0F), away from moisture and heat. Keep in original blister. Do not use after the printed expiry date.<\/p>\n Choose naftopidil if your main complaint is urgency, frequency, or nocturia; or if you have had bothersome ejaculation side effects on tamsulosin; or if you prefer a drug with a lower sexual side-effect rate. Tamsulosin remains first-line for Western guidelines for pure voiding-symptom BPH.<\/p>\n Improvement typically begins within 1\u20132 weeks. Peak effect at 4\u20138 weeks. Unlike 5-alpha-reductase inhibitors, naftopidil does not shrink the prostate \u2014 its effect is pharmacological smooth-muscle relaxation.<\/p>\n Much less than tamsulosin. Naftopidil’s alpha-1D preference means less effect on bladder-neck closure during ejaculation. This is naftopidil’s main clinical advantage for men who are sexually active.<\/p>\n Yes \u2014 alpha-blocker + 5-alpha-reductase inhibitor is a standard combination. Naftopidil addresses symptoms; dutasteride shrinks the prostate over 3\u20136 months. Not available as a fixed-dose combination, so take separately.<\/p>\n With caution \u2014 additive blood-pressure lowering. Tadalafil 5 mg daily is often pragmatic and also treats BPH. Space doses by several hours and monitor for dizziness.<\/p>\n Modest lowering effect. Not sufficient for hypertension monotherapy in most patients, but enough to cause orthostatic dizziness, especially at initiation. First dose should be at bedtime.<\/p>\n Developed by Japan’s Asahi Kasei Pharma, naftopidil received regulatory approval in Japan (1999) and other East Asian markets but not in the US. Recent studies support its role, particularly for storage-symptom-predominant BPH, and it is increasingly available in generic form globally.<\/p>\n Yes \u2014 naftopidil is associated with Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery, similar to other alpha-blockers. Tell your ophthalmologist before any eye surgery so technique can be adjusted.<\/p>\n \u2695\ufe0f \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e \u043f\u0440\u0435\u0434\u0443\u043f\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u0435:<\/strong> \u0422\u0430\u0437\u0438 \u0438\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u044f \u0435 \u0441 \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u0442\u0435\u043b\u043d\u0430 \u0446\u0435\u043b \u0438 \u043d\u0435 \u0437\u0430\u043c\u0435\u0441\u0442\u0432\u0430 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438 \u0441\u044a\u0432\u0435\u0442. \u041a\u043e\u043d\u0441\u0443\u043b\u0442\u0438\u0440\u0430\u0439\u0442\u0435 \u0441\u0435 \u0441 \u043b\u0435\u043a\u0430\u0440 \u043f\u0440\u0435\u0434\u0438 \u0437\u0430\u043f\u043e\u0447\u0432\u0430\u043d\u0435, \u0441\u043f\u0438\u0440\u0430\u043d\u0435 \u0438\u043b\u0438 \u043f\u0440\u043e\u043c\u044f\u043d\u0430 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e. \u041f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0438 \u043f\u043e \u0440\u0435\u0446\u0435\u043f\u0442\u0430 \u0442\u0440\u044f\u0431\u0432\u0430 \u0434\u0430 \u0441\u0435 \u0438\u0437\u043f\u043e\u043b\u0437\u0432\u0430\u0442 \u0441\u0430\u043c\u043e \u043f\u043e\u0434 \u043b\u0435\u043a\u0430\u0440\u0441\u043a\u0438 \u043d\u0430\u0434\u0437\u043e\u0440.<\/p>\n<\/div>\n <\/p>\n \u0414\u0440\u0443\u0433\u0438 \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0438 \u0432 \u041c\u044a\u0436\u043a\u043e \u0437\u0434\u0440\u0430\u0432\u0435<\/strong> \u043a\u043e\u0438\u0442\u043e \u043a\u043b\u0438\u0435\u043d\u0442\u0438\u0442\u0435 \u0441\u044a\u0449\u043e \u0440\u0430\u0437\u0433\u043b\u0435\u0436\u0434\u0430\u0442:<\/p>\n \u2705 Improves urinary flow Nafodil contains Naftopidil.<\/p>","protected":false},"featured_media":59280,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3202,3141,3142],"product_tag":[4667,4668],"class_list":{"0":"post-59279","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-benign-prostatic-hyperplasia-bph-treatment","7":"product_cat-category-overview","8":"product_cat-mens-health","9":"product_tag-nafodil","10":"product_tag-naftopidil","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product\/59279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/comments?post=59279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/media\/59280"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/media?parent=59279"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_brand?post=59279"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_cat?post=59279"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_tag?post=59279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0417\u0430\u0449\u043e \u0434\u0430 \u043f\u043e\u0440\u044a\u0447\u0432\u0430\u0442\u0435 \u043e\u0442 MedsBase<\/h3>\n
What Is Nafodil?<\/strong><\/h2>\n
\n
\u041a\u043b\u0438\u043d\u0438\u0447\u043d\u0438 \u043f\u0440\u0438\u043b\u043e\u0436\u0435\u043d\u0438\u044f<\/strong><\/h2>\n
\n
\u041a\u0430\u043a \u0441\u0435 \u043f\u0440\u0438\u0435\u043c\u0430<\/strong><\/h2>\n
\n
\u0421\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438<\/strong><\/h2>\n
Who Should Not Take Nafodil<\/strong><\/h2>\n
\n
\u041b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u0438 \u0432\u0437\u0430\u0438\u043c\u043e\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044f<\/strong><\/h2>\n
\n
Naftopidil vs Tamsulosin<\/strong><\/h2>\n
\n
\u0421\u044a\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u0435<\/strong><\/h2>\n
\u0427\u0435\u0441\u0442\u043e \u0437\u0430\u0434\u0430\u0432\u0430\u043d\u0438 \u0432\u044a\u043f\u0440\u043e\u0441\u0438<\/h2>\n
When should I choose naftopidil over tamsulosin?<\/h3>\n
How fast does Nafodil work?<\/h3>\n
Does naftopidil affect ejaculation?<\/h3>\n
Can I combine Nafodil with dutasteride?<\/h3>\n
Can I combine Nafodil with tadalafil?<\/h3>\n
Does Nafodil affect blood pressure?<\/h3>\n
Why is naftopidil less common in the West?<\/h3>\n
Should I tell my ophthalmologist I am on Nafodil?<\/h3>\n
\u0421\u0432\u044a\u0440\u0437\u0430\u043d\u0438 \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0438 \u0437\u0430 \u0414\u0417\u0414\u041f<\/h3>\n
\n
\u0421\u0432\u044a\u0440\u0437\u0430\u043d\u0438 \u0430\u043b\u0442\u0435\u0440\u043d\u0430\u0442\u0438\u0432\u0438<\/h3>\n
\n
\n\u2705 Reduces prostate size
\n\u2705 \u041e\u0431\u043b\u0435\u043a\u0447\u0430\u0432\u0430 \u0443\u0440\u0438\u043d\u0430\u0440\u043d\u0438 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u0438
\n\u2705 Enhances bladder emptying
\n\u2705 Minimizes urinary urgency<\/p>\n